Product Name | Osilodrostat (LCI699) |
---|---|
CAS | 928134-65-0 |
Formula | C13H10FN3 |
MW | 227.24 |
Appearance | White to yellow pwder |
Storage condition | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Size | Availability | Price(USD) | VIP Price (USD) | Quantity |
---|---|---|---|---|
1 mg | 3-5days | ¥350.00 | Visible after login | |
5 mg | 3-5days | ¥660.00 | Visible after login | |
10 mg | 3-5days | ¥1150.00 | Visible after login |
Product Name | Osilodrostat (LCI699) |
---|---|
CAS | 928134-65-0 |
Formula | C13H10FN3 |
MW | 227.24 |
Appearance | White to yellow pwder |
Storage condition | Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years). |
Osilodrostat, also known as LCI699, is a potent inhibitor of 11β-hydroxylase, the enzyme which catalyzes the final step of cortisol synthesis. LCI699 may thus be a potential new treatment for all forms of Cushing's syndrome. Current evidence indicates that the novel aldosterone inhibitor LCI699 is an effective and well-tolerated antihypertensive agent that lowers plasma aldosterone concentration and produces a mild ACTH-stimulated cortisol response suppressive effect.